SABCS 2023 Breast Cancer Highlights - NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

In discussion with Dr. Eleonora Teplinsky, covering the San Antonio Breast Cancer Symposium 2023 Highlights from Community Oncology perspective. We covered 4 important practice informing studies with Dr. Teplinsky:
- NSABP B-51 - Loco-regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node Negative After Neoadjuvant Chemotherapy
- IDEA Update - Five-year Outcomes of the IDEA trial of Endocrine Therapy Without Radiotherapy After Breast-Conserving Surgery for Postmenopausal Patients Aged 50-69 With Genomically-Selected Favorable Stage I Breast Cancer
- ICARO - Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated with Axillary Dissection or Nodal Radiation
- Keynote-522 Update - Event Free Survival with neoadjuvant and adjuvant pembrolizumab in TNBC
#SABCS #RadiationTherapy #Pembrolizumab #Breast #Cancer #2023 #oncology #oncbrothers
Website: www.oncbrothers.com/
Twitter: / oncbrothers
Contact us at [e-mail]